ALTUMOMAB
UNII AT2NU9VQ6M

Substance Identification & Data

This profile provides standardized clinical and technical data for Altumomab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) AT2NU9VQ6M.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 156586-92-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
AT2NU9VQ6M
CAS Registry Number
156586-92-4
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
ALTUMOMAB
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
INN ID
7046
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Altumomab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ALTUMOMAB

Common Names & Synonyms

ALTUMOMAB [INN]
IMMUNOGLOBULIN G1(MOUSE MONOCLONAL ZCEOZI ANTI-HUMAN ANTIGENCEA), DISUFFIDE WITH MOUSE MONOCLONAL ZCEOZSLIGHT CHAIN, DIMER
IMMUNOGLOBULIN G1, ANTI-(HUMAN CARCINOEMBRYONIC ANTIGEN) (MOUSE MONOCLONAL ZCE025 .GAMMA.1-CHAIN), DISULFIDE WITH MOUSE MONOCLONAL ZCE025 LIGHT CHAIN, DIMER

Technical Codes

MAB-35
ZCE-025